Language
Country/Area
No result found
Did you know how the evolution of Roman standards improved the treatment of gastroenterology?
In the diagnosis and treatment of gastrointestinal diseases, the Rome Standards, as an international effort, continue to improve and bring significant results. Many functional gastrointestinal disorders (FGIDs), such as irritable bowel syndrome and functional dyspepsia, are more accurately diagnosed using this criterion, leading to improved treatment outcomes. The development of this standard did not happen overnight, but went through many important meetings and consensus building.
The evolution of the Roman Criteria reflects continued exploration and scholarly efforts in the diagnosis of functional gastrointestinal disorders.
The Roman Standard grew out of a series of influential events. In 1962, Chaudhary and Truelove's research in Oxford, England, made the first attempt to classify irritable bowel syndrome. In 1978, the Manning criteria were proposed to provide a clearer basis for the diagnosis of IBS. Over time, these standards were further formed and developed into the Roman standards.
The accelerated pace of the Rome Criteria can be traced back to 1989, when the first set of consensus-based diagnostic criteria for irritable bowel syndrome was established, which is also considered the year of the birth of the Rome Criteria. Between 1991 and 1993, experts from different disciplines formed a working group and began to collaborate to develop symptom standards for various gastrointestinal diseases. These further efforts culminated in the 1994 book Functional Gastrointestinal Disorders: A Multinational Consensus on Diagnosis, Pathophysiology, and Treatment (Rome I).
The Rome criteria have been continuously updated since 1994 and cover diseases including 33 functional gastrointestinal disorders in adults and 17 in children.
The updating of Rome standards continues to improve the systematicness and effectiveness of research. For example, the Rome II criteria include diagnostic criteria for gastrointestinal diseases in children, while Rome III emphasizes an evidence-based decision-making approach. The current Rome IV criteria not only improve upon symptom-oriented criteria but also focus on global education and cross-cultural differences.
The process upon which this standard evolved is based on the Delphi method, a method of obtaining information through expert consensus that aims to gather the opinions of all parties to form a conclusion. The establishment and operation of the Rome Foundation have further promoted international research and practice on gastrointestinal diseases, providing support for improved diagnosis and treatment, whether through consensus meetings or survey methods.
The mission of the Rome Foundation is to improve the quality of life for people with functional gastrointestinal disorders and to translate scientific understanding into practice.
As the Roman criteria have evolved to the current IV version, their classification system has become more refined, covering relevant physiological, psychological and social factors, and is more suitable for clinical needs. The proposal of the MDCP system is another innovation that combines clinical diagnosis updates with patients' individualized treatment plans, allowing medical providers to provide more effective treatments based on the patient's specific conditions.
In today's medical community, the cooperation between scholars and foundations is no longer limited to European and American countries, but has gradually extended to Asia and other regions, which is promoting awareness and understanding of the disease around the world. During the development process, it became apparent that a focus on patient history, cultural differences, and improving symptom presentation were all important factors in its success.
The continued evolution of the Roman Criteria demonstrates a deepening understanding of functional gastrointestinal diseases and facilitates more precise treatment.
Ultimately, the success of the Rome Criteria lies not only in providing a unified diagnostic system, but also in promoting global understanding and research on functional gastrointestinal diseases. With the advancement of medicine, will future development continue to work toward improving the quality of life of more patients?
